{"transactions":[{"id":4628572,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":45730,"kind":"person","name":"Foundation Fighting Blindness Retinal Degeneration Fund","position":1,"cik":"0002042266","reported_name":"Foundation Fighting Blindness Retinal Degeneration Fund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":45731,"kind":"person","name":"Foundation Fighting Blindness, Inc.","position":2,"cik":"0002042532","reported_name":"Foundation Fighting Blindness, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-02T23:47:01.000Z","date":"2026-09-30","kind":"sale","planned":false,"acquired":false,"shares":556000,"price":4.9568,"value":2755980.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $4.95 to $5.29. The price reported in Column 4 is a weighted average price. The Reporting Persons hereby undertake to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Foundation Fighting Blindness, Inc. (\"FFB\") is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund (\"RDF\") and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold."}],"balance_after":3236171,"source":{"system":"sec-edgar","filing":"0002042266-26-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042532/000204226626000002/primary_doc.xml","form_type":"4"}},{"id":770292,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":45730,"kind":"person","name":"Foundation Fighting Blindness Retinal Degeneration Fund","position":1,"cik":"0002042266","reported_name":"Foundation Fighting Blindness Retinal Degeneration Fund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":45731,"kind":"person","name":"Foundation Fighting Blindness, Inc.","position":2,"cik":"0002042532","reported_name":"Foundation Fighting Blindness, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-20T23:29:44.000Z","date":"2026-05-18","kind":"sale","planned":false,"acquired":false,"shares":1700000,"price":4.35,"value":7395000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Foundation Fighting Blindness, Inc. (\"FFB\") is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund (\"RDF\") and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold."}],"balance_after":3792171,"source":{"system":"sec-edgar","filing":"0002042266-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042532/000204226626000001/primary_doc.xml","form_type":"4"}},{"id":972855,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":45730,"kind":"person","name":"Foundation Fighting Blindness Retinal Degeneration Fund","position":1,"cik":"0002042266","reported_name":"Foundation Fighting Blindness Retinal Degeneration Fund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":45731,"kind":"person","name":"Foundation Fighting Blindness, Inc.","position":2,"cik":"0002042532","reported_name":"Foundation Fighting Blindness, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-11T22:35:47.000Z","date":"2025-12-09","kind":"sale","planned":false,"acquired":false,"shares":4000000,"price":2.15,"value":8600000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Foundation Fighting Blindness, Inc. (\"FFB\") is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund (\"RDF\") and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold."}],"balance_after":5492171,"source":{"system":"sec-edgar","filing":"0002042266-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042532/000204226625000003/primary_doc.xml","form_type":"4"}},{"id":1157611,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":45730,"kind":"person","name":"Foundation Fighting Blindness Retinal Degeneration Fund","position":1,"cik":"0002042266","reported_name":"Foundation Fighting Blindness Retinal Degeneration Fund","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":45731,"kind":"person","name":"Foundation Fighting Blindness, Inc.","position":2,"cik":"0002042532","reported_name":"Foundation Fighting Blindness, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Series A Non-Voting Convertible Preferred Stock","published_at":"2025-05-06T22:05:27.000Z","date":"2025-05-05","kind":"exercise","planned":false,"acquired":false,"shares":6927.419,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A non-voting convertible preferred stock (the \"Preferred Stock\") automatically converted into 1,000 shares of the Issuer's common stock as of 5:00 p.m. Eastern time on the third business day after the date that the Issuer's stockholders approved the conversion of the Preferred Stock into shares of the Issuer's common stock, which approval occurred on April 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares of Preferred Stock were issued to the Reporting Persons in connection with a merger and reorganization in a stock-for-stock transaction."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A non-voting convertible preferred stock (the \"Preferred Stock\") automatically converted into 1,000 shares of the Issuer's common stock as of 5:00 p.m. Eastern time on the third business day after the date that the Issuer's stockholders approved the conversion of the Preferred Stock into shares of the Issuer's common stock, which approval occurred on April 30, 2025."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Foundation Fighting Blindness, Inc. (\"FFB\") is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund (\"RDF\") and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold."}],"balance_after":0,"derivative":{"exercise_date":"2025-05-05","underlying":"Common Stock","underlying_shares":6927419},"source":{"system":"sec-edgar","filing":"0001578563-25-000238","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042532/000157856325000238/primary_doc.xml","form_type":"4"}},{"id":1157610,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":45730,"kind":"person","name":"Foundation Fighting Blindness Retinal Degeneration Fund","position":1,"cik":"0002042266","reported_name":"Foundation Fighting Blindness Retinal Degeneration Fund","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":45731,"kind":"person","name":"Foundation Fighting Blindness, Inc.","position":2,"cik":"0002042532","reported_name":"Foundation Fighting Blindness, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2025-05-06T22:05:27.000Z","date":"2025-05-05","kind":"exercise","planned":false,"acquired":true,"shares":6927419,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A non-voting convertible preferred stock (the \"Preferred Stock\") automatically converted into 1,000 shares of the Issuer's common stock as of 5:00 p.m. Eastern time on the third business day after the date that the Issuer's stockholders approved the conversion of the Preferred Stock into shares of the Issuer's common stock, which approval occurred on April 30, 2025."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Foundation Fighting Blindness, Inc. (\"FFB\") is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund (\"RDF\") and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold."}],"balance_after":9492171,"source":{"system":"sec-edgar","filing":"0001578563-25-000238","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042532/000157856325000238/primary_doc.xml","form_type":"4"}}]}